e-ETPichtyose: Therapeutic Education Using an Internet Application in Hereditary Ichthyosis

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Unknown status
CT.gov ID
NCT03641261
Collaborator
(none)
42
1
1
39.1
1.1

Study Details

Study Description

Brief Summary

The main purpose is to evaluate the feasibility (global use) of a therapeutic patient education program using a specific web application in patients with hereditary ichthyosis.

Condition or Disease Intervention/Treatment Phase
  • Other: Therapeutic patient education program
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Feasibility and Effect of Therapeutic Education Sessions Using an Internet Application in Hereditary Ichthyosis
Actual Study Start Date :
Oct 29, 2018
Anticipated Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Therapeutic Patient Education program

All included patients will follow a Therapeutic Patient Education program dedicated to the hereditary ichthyosis and using a web application, WebIchtyose

Other: Therapeutic patient education program
WebIchtyose is a specific therapeutic patient education program for patients with hereditary Ichthyosis targeting the problems of each patient by means of a personalized follow-up and a constant interaction between the patient and the educational team
Other Names:
  • WebIchtyose
  • Outcome Measures

    Primary Outcome Measures

    1. Global use [6 months]

      percentage of patients who have used the "WebIchtyose" application for at least 8 hours during 6 months

    Secondary Outcome Measures

    1. Fractional use in each domain (educational sessions) [6 months]

      "WebIchtyose" application use time by the patient for group and individual educational sessions

    2. Fractional use in each domain (continuous educational follow-up) [6 months]

      "WebIchtyose" application use time by the patient for the continuous educational follow-up

    3. Fractional use in each domain (consultation) [6 months]

      "WebIchtyose" application use time by the patient for the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application

    4. Fractional use in each domain (questionnaires) [6 months]

      "WebIchtyose" application use time by the patient for the filling of the questionnaires

    5. Fractional use in each domain [6 months]

      "WebIchtyose" application use time by the patient for group and individual educational sessions, the continuous educational follow-up, the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application

    6. Difficulty of individual application registration [Baseline]

      Difficulty of registration questionnaire completed for each patient jointly by the patient and the educational team at the end of the face-to-face inclusion visit

    7. Difficulties of use in everyday life by the patient [6 months]

      Questionnaire completed for each patient jointly by the patient at the end of the program

    8. Number of exchanges [3 months and 5 months]

      Number of exchanges necessary between the educational team and the patient to set a date for the conduct of the individual educational sessions

    9. Response time [6 months]

      Response time of the educational team following a request from the patient as part of the educational follow-up

    10. Number of relaunches [2 months, 4 months and 6 months]

      How many times the nurse relaunches the patient to obtain the assessment questionnaires

    11. Number of non-received questionnaires [2 months, 4 months and 6 months]

      Number of non-received questionnaires after relaunch

    12. Number of lost to follow-up patients [9 months]

      Number of lost to follow-up patients

    13. Patient acceptability [6 months]

      Acceptability questionnaire to be completed by the patient

    14. Educational team acceptability [6 months]

      Acceptability questionnaire to be completed by each member of the educational team

    15. Attractiveness [6 months]

      Application attractiveness questionnaire completed by the patient

    16. Quality of life before and after treatment [Inclusion, 6 months and 9 months]

      Quality of life questionnaire for hereditary ichthyosis (IQoL-32)

    17. Self-assessment of cutaneous severity [Inclusion and 6 months]

      Self-assessment of cutaneous severity according to an analogic visual scale for pain, pruritus, erythema, squama

    18. Knowledge about disease and treatments [Inclusion and 6 months]

      Questionnaire of knowledge about disease and treatments

    19. Self-care skills [Inclusion and 6 months]

      Questionnaire of self-care skills

    20. Self-esteem [Inclusion and 6 months]

      Questionnaire about self-esteem: Rosenberg scale. For each item of the questionnaire, the modality answers are : 1 (totally disagree), 2 (quite disagree), 3 (quite agree) and 4 (totally disagree). The total score (/ 40) is calculated by adding the scores obtained for each item.

    21. Coping scale [Inclusion and 6 months]

      Coping with health injuries and problem (Endler 1998). For each item of the questionnaire, the modality answers are: 1 (not at all), 2 (a little), 3 (moderately), 4 (often) and 5 (a lot).The total score (/ 160) is calculated by adding the scores obtained for each item.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient with hereditary ichthyosis, according to the classification established during the 2009 consensus conference

    • Who has given his informed consent form

    • Who is affiliated to a social security system

    Exclusion Criteria:
    • Patient who has already participated in a therapeutic patient education program for the hereditary ichthyosis

    • Unable to connect or use a computer tool

    • Impossibility to be present at the only face-to-face session

    • Patient who is not available for the collective educational session

    • Patient with little or no motivation to follow a therapeutic patient education program (motivation evaluated by the educational team by phone call before inclusion)

    • Patient not mastering the French language

    • Person under legal protection (guardianship, curators or safeguard of justice)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU Toulouse, Hôpital Larrey Toulouse France 31059

    Sponsors and Collaborators

    • University Hospital, Toulouse

    Investigators

    • Principal Investigator: Juliette Mazereeuw-Hautier, MD, University Hospital, Toulouse

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Toulouse
    ClinicalTrials.gov Identifier:
    NCT03641261
    Other Study ID Numbers:
    • RC31/16/8765
    First Posted:
    Aug 21, 2018
    Last Update Posted:
    Aug 25, 2020
    Last Verified:
    Aug 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Toulouse
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 25, 2020